⌘K

Login Start Free

Home/Filings/4/0001104659-22-072175

4//SEC Filing

Avnur Zafrira 4

Accession 0001104659-22-072175

CIK 0001035354other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 8:23 AM ET

Size

5.6 KB

Accession

0001104659-22-072175

Insider Transaction Report

Form 4

Period: 2022-06-15

Eloxx Pharmaceuticals, Inc.ELOX

Director

Transactions

Award
Stock Options (Right to Buy)
2022-06-15+20,000→ 20,000 total
Exercise: $0.26Exp: 2032-06-15→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal installments thereafter.

Documents

1 file

4
tm2218714-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1

filerCIK 0001726049

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 8:23 AM ET
Size: 5.6 KB

View on SEC.gov